Samanta Salvi
Biosciences Laboratory
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
Samanta Salvi has not added Biography.
If you are Samanta Salvi and would like to personalize this page please email our Author Liaison for assistance.
Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study.
BioMed research international , 2013 | Pubmed ID: 23509700
Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer.
International journal of molecular sciences Jul, 2014 | Pubmed ID: 25026175
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients.
Disease markers , 2015 | Pubmed ID: 26412928
Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.
Molecular diagnosis & therapy Feb, 2016 | Pubmed ID: 26518421
Plasma AR and abiraterone-resistant prostate cancer.
Science translational medicine Nov, 2015 | Pubmed ID: 26537258
CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone.
The International journal of biological markers Jul, 2016 | Pubmed ID: 26954071
Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy Aug, 2016 | Pubmed ID: 27177757
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.
Oncotarget Jun, 2016 | Pubmed ID: 27191887
miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer.
OncoTargets and therapy , 2016 | Pubmed ID: 27226732
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.
Journal of translational medicine Aug, 2016 | Pubmed ID: 27576364
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications.
Disease markers , 2016 | Pubmed ID: 27594734
The potential use of urine cell free DNA as a marker for cancer.
Expert review of molecular diagnostics Dec, 2016 | Pubmed ID: 27796148
Cell-free DNA as a diagnostic marker for cancer: current insights.
OncoTargets and therapy , 2016 | Pubmed ID: 27822059
Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer.
Oncotarget Nov, 2016 | Pubmed ID: 27861150
Vitamin D status among long-term survivors of testicular cancer.
Oncotarget Dec, 2016 | Pubmed ID: 28030821
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer.
Oncotarget Mar, 2017 | Pubmed ID: 28186965
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.
Nature communications Nov, 2017 | Pubmed ID: 29180617
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.
Nature communications Jan, 2018 | Pubmed ID: 29311577
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved